{"id":3652,"date":"2024-09-16T04:00:44","date_gmt":"2024-09-16T08:00:44","guid":{"rendered":"https:\/\/happylungsproject.org\/?p=3652"},"modified":"2026-03-02T10:53:07","modified_gmt":"2026-03-02T15:53:07","slug":"from-safety-to-approval-ret-lung-cancer-clinical-trial-phases","status":"publish","type":"post","link":"https:\/\/happylungsproject.org\/from-safety-to-approval-ret-lung-cancer-clinical-trial-phases\/","title":{"rendered":"From Safety to Approval: RET Lung Cancer Clinical Trial Phases"},"content":{"rendered":"[vc_row type=&#8221;in_container&#8221; full_screen_row_position=&#8221;middle&#8221; column_margin=&#8221;default&#8221; column_direction=&#8221;default&#8221; column_direction_tablet=&#8221;default&#8221; column_direction_phone=&#8221;default&#8221; scene_position=&#8221;center&#8221; text_color=&#8221;dark&#8221; text_align=&#8221;left&#8221; row_border_radius=&#8221;none&#8221; row_border_radius_applies=&#8221;bg&#8221; overflow=&#8221;visible&#8221; overlay_strength=&#8221;0.3&#8243; gradient_direction=&#8221;left_to_right&#8221; shape_divider_position=&#8221;bottom&#8221; bg_image_animation=&#8221;none&#8221; shape_type=&#8221;&#8221;][vc_column column_padding=&#8221;no-extra-padding&#8221; column_padding_tablet=&#8221;inherit&#8221; column_padding_phone=&#8221;inherit&#8221; column_padding_position=&#8221;all&#8221; column_element_direction_desktop=&#8221;default&#8221; column_element_spacing=&#8221;default&#8221; desktop_text_alignment=&#8221;default&#8221; tablet_text_alignment=&#8221;default&#8221; phone_text_alignment=&#8221;default&#8221; background_color_opacity=&#8221;1&#8243; background_hover_color_opacity=&#8221;1&#8243; column_backdrop_filter=&#8221;none&#8221; column_shadow=&#8221;none&#8221; column_border_radius=&#8221;none&#8221; column_link_target=&#8221;_self&#8221; column_position=&#8221;default&#8221; gradient_direction=&#8221;left_to_right&#8221; overlay_strength=&#8221;0.3&#8243; width=&#8221;1\/1&#8243; tablet_width_inherit=&#8221;default&#8221; animation_type=&#8221;default&#8221; bg_image_animation=&#8221;none&#8221; border_type=&#8221;simple&#8221; column_border_width=&#8221;none&#8221; column_border_style=&#8221;solid&#8221;][vc_row_inner column_margin=&#8221;default&#8221; column_direction=&#8221;default&#8221; column_direction_tablet=&#8221;default&#8221; column_direction_phone=&#8221;default&#8221; text_align=&#8221;left&#8221; row_position=&#8221;default&#8221; row_position_tablet=&#8221;inherit&#8221; row_position_phone=&#8221;inherit&#8221; overflow=&#8221;visible&#8221; pointer_events=&#8221;all&#8221;][vc_column_inner column_padding=&#8221;padding-3-percent&#8221; column_padding_tablet=&#8221;inherit&#8221; column_padding_phone=&#8221;inherit&#8221; column_padding_position=&#8221;all&#8221; column_element_direction_desktop=&#8221;default&#8221; column_element_spacing=&#8221;default&#8221; desktop_text_alignment=&#8221;default&#8221; tablet_text_alignment=&#8221;default&#8221; phone_text_alignment=&#8221;default&#8221; background_color=&#8221;#f68d28&#8243; background_color_opacity=&#8221;1&#8243; background_hover_color_opacity=&#8221;1&#8243; column_backdrop_filter=&#8221;none&#8221; font_color=&#8221;#ffffff&#8221; column_shadow=&#8221;none&#8221; column_border_radius=&#8221;10px&#8221; column_link_target=&#8221;_self&#8221; overflow=&#8221;visible&#8221; gradient_direction=&#8221;left_to_right&#8221; overlay_strength=&#8221;0.3&#8243; width=&#8221;1\/1&#8243; tablet_width_inherit=&#8221;default&#8221; animation_type=&#8221;default&#8221; bg_image_animation=&#8221;none&#8221; border_type=&#8221;simple&#8221; column_border_width=&#8221;none&#8221; column_border_style=&#8221;solid&#8221; column_padding_type=&#8221;default&#8221; gradient_type=&#8221;default&#8221;][vc_column_text css=&#8221;&#8221; text_direction=&#8221;default&#8221;]\n<p data-pm-slice=\"1 1 []\"><span data-color=\"var(--orange-10)\">Clinical trial phases build upon one another, contributing to a comprehensive understanding of a treatment&#8217;s safety, effectiveness, and optimal use. The clinical trials phased approach ensures that new treatments are thoroughly evaluated before they are widely available, ultimately protecting patients and improving outcomes. <\/span><\/p>\n[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner column_margin=&#8221;default&#8221; column_direction=&#8221;default&#8221; column_direction_tablet=&#8221;default&#8221; column_direction_phone=&#8221;default&#8221; text_align=&#8221;left&#8221; row_position=&#8221;default&#8221; row_position_tablet=&#8221;inherit&#8221; row_position_phone=&#8221;inherit&#8221; overflow=&#8221;visible&#8221; pointer_events=&#8221;all&#8221;][vc_column_inner column_padding=&#8221;no-extra-padding&#8221; column_padding_tablet=&#8221;inherit&#8221; column_padding_phone=&#8221;inherit&#8221; column_padding_position=&#8221;all&#8221; column_element_direction_desktop=&#8221;default&#8221; column_element_spacing=&#8221;default&#8221; desktop_text_alignment=&#8221;default&#8221; tablet_text_alignment=&#8221;default&#8221; phone_text_alignment=&#8221;default&#8221; background_color_opacity=&#8221;1&#8243; background_hover_color_opacity=&#8221;1&#8243; column_backdrop_filter=&#8221;none&#8221; column_shadow=&#8221;none&#8221; column_border_radius=&#8221;none&#8221; column_link_target=&#8221;_self&#8221; overflow=&#8221;visible&#8221; gradient_direction=&#8221;left_to_right&#8221; overlay_strength=&#8221;0.3&#8243; width=&#8221;1\/1&#8243; tablet_width_inherit=&#8221;default&#8221; animation_type=&#8221;default&#8221; bg_image_animation=&#8221;none&#8221; border_type=&#8221;simple&#8221; column_border_width=&#8221;none&#8221; column_border_style=&#8221;solid&#8221;][vc_column_text css=&#8221;&#8221; text_direction=&#8221;default&#8221;]\n<p data-pm-slice=\"1 3 []\">Clinical trials play a pivotal role in advancing medical research and developing effective treatments for various diseases, including RET lung cancer. These trials are structured in phases, each serving a distinct purpose in evaluating a new treatment&#8217;s safety, efficacy, and overall impact. Let&#8217;s explore the phases of clinical trials, shedding light on what each phase entails and how clinical trials activate medical progress.<\/p>\n<h2><strong>The Investigational New Drug Process<\/strong><\/h2>\n<p>An Investigational New Drug Application (IND) is a request for authorization from the Food and Drug Administration (FDA) to administer an investigational drug or biological product to humans.<\/p>\n<p>Principal investigators, drug developers, or sponsors must submit an Investigational New Drug (IND) application to the FDA before beginning a clinical trial. The request includes animal study data and toxicity, manufacturing information, clinical trial plans to be conducted, data from any prior human research, and information about the investigator.<\/p>\n<p>The primary objectives in reviewing a new drug are:<\/p>\n<ul>\n<li>To assure the safety and rights of subjects in all phases of an investigation<\/li>\n<li>To help assure that the quality of the scientific evaluation of the drug is adequate to permit an evaluation of the drug&#8217;s effectiveness and safety in phases II and III studies<\/li>\n<\/ul>\n[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][toggles style=&#8221;minimal_shadow&#8221; accordion=&#8221;true&#8221; accordion_starting_functionality=&#8221;closed&#8221; border_radius=&#8221;none&#8221;][toggle color=&#8221;Accent-Color&#8221; heading_tag=&#8221;h3&#8243; heading_tag_functionality=&#8221;default&#8221; title=&#8221;Phase I&#8221;][vc_column_text css=&#8221;&#8221; text_direction=&#8221;default&#8221;]\n<h2>Assessing Safety and Determining Dosage<\/h2>\n<p>Phase I trials represent the initial step in testing new treatments. The primary focus at this stage is to ensure the treatment&#8217;s safety in humans and to determine the optimal dosage.<\/p>\n<h3><strong>What Happens in Phase I?<\/strong><\/h3>\n<p>In Phase I, researchers are primarily focused on safety. They test a new treatment on a small group of people, usually 15-50 patients, to ensure it does not cause harmful side effects. The focus is on finding a safe dosage and observing how the cancer treatment is metabolized by the body.<\/p>\n<h3><strong>Why Is Phase I Important?<\/strong><\/h3>\n<p>Ensuring patient safety is crucial. Before a cancer treatment can be used more widely, researchers must be sure it&#8217;s not harmful. Phase I allows them to monitor patients closely, gathering critical information on how the body reacts to the treatment.<\/p>\n<h3><strong>Who Participates in Phase I?<\/strong><\/h3>\n<p>If a new drug is intended for use in cancer patients, researchers conduct Phase I studies in patients with that type of cancer. These participants help pave the way for new treatments by contributing to research that could benefit future patients.<\/p>\n<p>By the end of Phase I, scientists have a clearer understanding of the treatment&#8217;s safety profile and dose, and they can move forward with confidence.[\/vc_column_text][\/toggle][toggle color=&#8221;Accent-Color&#8221; heading_tag=&#8221;h3&#8243; heading_tag_functionality=&#8221;default&#8221; title=&#8221;Phase II&#8221;][vc_column_text css=&#8221;&#8221; text_direction=&#8221;default&#8221;]\n<h2>Evaluating Efficacy and Monitoring Side Effects<\/h2>\n<p>Phase II trials build upon the results of Phase I by focusing on the treatment&#8217;s efficacy and side effects in a larger group of participants. These trials typically involve fewer than 100 patients, providing a more extensive data set for researchers to analyze. During this phase, the primary objective is to assess how well the treatment works in combating RET lung cancer and to identify any side effects that might emerge.<\/p>\n<h3>What Happens in Phase II?<\/h3>\n<p>Phase II trials expand the testing to a larger group of patients, generally fewer than 100. Here, researchers assess the effectiveness of the treatment. Phase II studies provide researchers with additional safety data. Investigators watch for side effects and determine how well patients tolerate the treatment. Researchers use these data to refine research questions, develop research methods, and design new Phase III research protocols.<\/p>\n<h3>Why Is Phase II Important?<\/h3>\n<p>This phase provides a deeper look into the treatment&#8217;s potential. Researchers gather more data to determine if the treatment shows signs of effectiveness. This step is crucial to ensure the treatment has a real impact on the disease before moving to broader testing. Approximately 33% of drugs move to the next phase.<\/p>\n<h3>Who Participates in Phase II?<\/h3>\n<p>In Phase II studies, researchers administer the treatment to a group of patients with the disease or condition for which the drug is being developed. The results from Phase II guide further development and help determine whether the treatment should advance to Phase III.[\/vc_column_text][\/toggle][toggle color=&#8221;Accent-Color&#8221; heading_tag=&#8221;h3&#8243; heading_tag_functionality=&#8221;default&#8221; title=&#8221;Phase III&#8221;][vc_column_text css=&#8221;&#8221; text_direction=&#8221;default&#8221;]Phase III trials involve a significantly larger number of participants, often in the hundreds, allowing for a robust comparison between the new treatment and existing standard treatments. Successful completion is a key requirement for seeking regulatory approval.<\/p>\n<h3>What Happens in Phase III?<\/h3>\n<p>Phase III trials are much larger, involving hundreds of participants. At this stage, the new treatment is compared to the current standard treatments. Researchers aim to determine if the new treatment works better, has fewer side effects, or offers improved quality of life.<\/p>\n<h2>Comparing with Standard Treatments<\/h2>\n<h3>Why Is Phase III Important?<\/h3>\n<p>Phase III trials provide most of the safety data. By comparing the new treatment with existing options, researchers can show whether there is an improvement or not.<\/p>\n<h3>Who Participates in Phase III?<\/h3>\n<p>Phase III trials involve hundreds of participants. These trials often span multiple locations and are designed to include a wide variety of patients to ensure the results are widely applicable.[\/vc_column_text][\/toggle][toggle color=&#8221;Accent-Color&#8221; heading_tag=&#8221;h3&#8243; heading_tag_functionality=&#8221;default&#8221; title=&#8221;Phase IV&#8221;][vc_column_text css=&#8221;&#8221; text_direction=&#8221;default&#8221;]\n<h2 data-pm-slice=\"1 1 []\">Post-Approval Monitoring and Long-Term Assessment<\/h2>\n<p>Phase IV trials are carried out once the drug or device has been approved by FDA during the Post-Market Safety Monitoring. They are essential for monitoring the real-world performance of the treatment, identifying rare adverse effects, and assessing its impact on various patient populations in a longer term. The insights gained from Phase IV can lead to further refinements in treatment protocols and guide future research.<\/p>\n<h3><strong>What Happens in Phase IV?<\/strong><\/h3>\n<p>Phase IV begins after the treatment has been approved and is on the market. It involves thousands of participants and aims to monitor the long-term effects of the treatment. Researchers gather information on real-world use, identifying any rare or unexpected side effects.<\/p>\n<h3><strong>Why Is Phase IV Important?<\/strong><\/h3>\n<p>Even after a treatment is approved, it&#8217;s essential to continue monitoring its effects. Phase IV allows researchers to collect data on long-term safety and effectiveness. This ongoing monitoring helps ensure that the treatment remains safe for broader use and can guide future improvements.<\/p>\n<h3><strong>Who Participates in Phase IV?<\/strong><\/h3>\n<p>Phase IV trials involve a much larger group of people, typically those who are using the treatment as part of their standard care. This phase allows researchers to study the treatment&#8217;s impact in a real-world setting, providing valuable insights into its long-term benefits and risks.[\/vc_column_text][\/toggle][\/toggles][vc_row_inner column_margin=&#8221;default&#8221; column_direction=&#8221;default&#8221; column_direction_tablet=&#8221;default&#8221; column_direction_phone=&#8221;default&#8221; text_align=&#8221;left&#8221; row_position=&#8221;default&#8221; row_position_tablet=&#8221;inherit&#8221; row_position_phone=&#8221;inherit&#8221; overflow=&#8221;visible&#8221; pointer_events=&#8221;all&#8221;][vc_column_inner column_padding=&#8221;no-extra-padding&#8221; column_padding_tablet=&#8221;inherit&#8221; column_padding_phone=&#8221;inherit&#8221; column_padding_position=&#8221;all&#8221; column_element_direction_desktop=&#8221;default&#8221; column_element_spacing=&#8221;default&#8221; desktop_text_alignment=&#8221;default&#8221; tablet_text_alignment=&#8221;default&#8221; phone_text_alignment=&#8221;default&#8221; background_color_opacity=&#8221;1&#8243; background_hover_color_opacity=&#8221;1&#8243; column_backdrop_filter=&#8221;none&#8221; column_shadow=&#8221;none&#8221; column_border_radius=&#8221;none&#8221; column_link_target=&#8221;_self&#8221; overflow=&#8221;visible&#8221; gradient_direction=&#8221;left_to_right&#8221; overlay_strength=&#8221;0.3&#8243; width=&#8221;1\/1&#8243; tablet_width_inherit=&#8221;default&#8221; animation_type=&#8221;default&#8221; bg_image_animation=&#8221;none&#8221; border_type=&#8221;simple&#8221; column_border_width=&#8221;none&#8221; column_border_style=&#8221;solid&#8221;][vc_column_text css=&#8221;&#8221; text_direction=&#8221;default&#8221;]\n<h2 data-pm-slice=\"1 1 []\">The Importance of Clinical Trial Phases<\/h2>\n<p>Understanding the phases of RET lung cancer clinical trials is crucial for anyone interested in the development and approval process of new treatments. Each phase serves a unique purpose, from establishing safety in Phase I to assessing long-term outcomes in Phase IV. By following this structured approach, researchers can ensure that new treatments are both safe and effective, ultimately improving the lives of patients.<\/p>\n<h2>Lung Cancer Clinical Trials are Critical to Advance Research<\/h2>\n<p>RET-positive lung cancer patient participation in clinical trials is important to reveal potential treatment options and help researchers gather critical information upon which to base their research for improved treatment options. Clinical trials also offer hope to patients and their families.<\/p>\n<p>The Happy Lungs Project provides information about the latest clinical trials for RET-positive lung cancer patients. <a href=\"https:\/\/happylungsproject.org\/current-clinical-trials\/\" rel=\"noopener noreferrer\">Use our tool to match to a trial.<\/a><\/p>\n<p>If you have any questions about RET lung cancer clinical trials or would like to learn more about the latest advancements in RET lung cancer research, feel free to <a href=\"https:\/\/happylungsproject.org\/contact\/\"><strong>contact us<\/strong><\/a> for additional information.[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner column_margin=&#8221;default&#8221; column_direction=&#8221;default&#8221; column_direction_tablet=&#8221;default&#8221; column_direction_phone=&#8221;default&#8221; text_align=&#8221;left&#8221; row_position=&#8221;default&#8221; row_position_tablet=&#8221;inherit&#8221; row_position_phone=&#8221;inherit&#8221; overflow=&#8221;visible&#8221; pointer_events=&#8221;all&#8221;][vc_column_inner column_padding=&#8221;no-extra-padding&#8221; column_padding_tablet=&#8221;inherit&#8221; column_padding_phone=&#8221;inherit&#8221; column_padding_position=&#8221;all&#8221; column_element_direction_desktop=&#8221;default&#8221; column_element_spacing=&#8221;default&#8221; desktop_text_alignment=&#8221;default&#8221; tablet_text_alignment=&#8221;default&#8221; phone_text_alignment=&#8221;default&#8221; background_color_opacity=&#8221;1&#8243; background_hover_color_opacity=&#8221;1&#8243; column_backdrop_filter=&#8221;none&#8221; column_shadow=&#8221;none&#8221; column_border_radius=&#8221;none&#8221; column_link_target=&#8221;_self&#8221; overflow=&#8221;visible&#8221; gradient_direction=&#8221;left_to_right&#8221; overlay_strength=&#8221;0.3&#8243; width=&#8221;1\/1&#8243; tablet_width_inherit=&#8221;default&#8221; animation_type=&#8221;default&#8221; bg_image_animation=&#8221;none&#8221; border_type=&#8221;simple&#8221; column_border_width=&#8221;none&#8221; column_border_style=&#8221;solid&#8221;][vc_column_text css=&#8221;&#8221; text_direction=&#8221;default&#8221;]\n<h2 data-pm-slice=\"1 1 []\">References<\/h2>\n<ol>\n<li style=\"list-style-type: none;\">\n<ol>\n<li>National Cancer Institute: <a href=\"https:\/\/www.cancer.gov\/research\/participate\/clinical-trials\/how-trials-work\" rel=\"noopener noreferrer\">https:\/\/www.cancer.gov\/research\/participate\/clinical-trials\/how-trials-work<\/a><\/li>\n<li><a href=\"https:\/\/www.cc.nih.gov\/orcs\/ind1.html\" rel=\"noopener noreferrer\">https:\/\/www.cc.nih.gov\/orcs\/ind1.html<\/a><\/li>\n<li><a href=\"https:\/\/www.fda.gov\/patients\/drug-development-process\/step-3-clinical-research#:~:text=In%20most%20cases%2C%2020%20to,with%20that%20type%20of%20cancer\" rel=\"noopener noreferrer\">https:\/\/www.fda.gov\/patients\/drug-development-process\/step-3-clinical-research#:~:text=In%20most%20cases%2C%2020%20to,with%20that%20type%20of%20cancer<\/a>.<\/li>\n<li><a href=\"https:\/\/www.mdanderson.org\/patients-family\/diagnosis-treatment\/clinical-trials\/phases-of-clinical-trials.html\" rel=\"noopener noreferrer\">https:\/\/www.mdanderson.org\/patients-family\/diagnosis-treatment\/clinical-trials\/phases-of-clinical-trials.html<\/a><\/li>\n<\/ol>\n<\/li>\n<\/ol>\n[\/vc_column_text][vc_column_text css=&#8221;&#8221; text_direction=&#8221;default&#8221;]Your donation matters. Please make a gift today to <a href=\"https:\/\/happylungsproject.org\/donate\/\">support lung cancer research<\/a> and save lives.[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row]\n","protected":false},"excerpt":{"rendered":"<p>The clinical trials phased approach ensures that new treatments are thoroughly evaluated before they are widely available, ultimately protecting patients and improving outcomes.<\/p>\n","protected":false},"author":15,"featured_media":3654,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[22,10,20],"tags":[],"class_list":{"0":"post-3652","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-clinical-trials","8":"category-research","9":"category-treatment"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.1.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>From Safety to Approval: RET Lung Cancer Clinical Trial Phases<\/title>\n<meta name=\"description\" content=\"The lung cancer clinical trials phased approach ensures that new treatments are thoroughly evaluated before they are widely available.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/happylungsproject.org\/from-safety-to-approval-ret-lung-cancer-clinical-trial-phases\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"From Safety to Approval: RET Lung Cancer Clinical Trial Phases\" \/>\n<meta property=\"og:description\" content=\"The lung cancer clinical trials phased approach ensures that new treatments are thoroughly evaluated before they are widely available.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/happylungsproject.org\/from-safety-to-approval-ret-lung-cancer-clinical-trial-phases\/\" \/>\n<meta property=\"og:site_name\" content=\"The Happy Lungs Project\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/thehappylungsproject\" \/>\n<meta property=\"article:published_time\" content=\"2024-09-16T08:00:44+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-02T15:53:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/happylungsproject.org\/wp-content\/uploads\/2024\/09\/phase-I-trial-phase-ii-trial-phase-iii-trial-for-cancer-patients.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"813\" \/>\n\t<meta property=\"og:image:height\" content=\"621\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Irene Guijarro Munoz\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Irene Guijarro Munoz\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/happylungsproject.org\/from-safety-to-approval-ret-lung-cancer-clinical-trial-phases\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/happylungsproject.org\/from-safety-to-approval-ret-lung-cancer-clinical-trial-phases\/\"},\"author\":{\"name\":\"Irene Guijarro Munoz\",\"@id\":\"https:\/\/happylungsproject.org\/#\/schema\/person\/7f7dfd38ae877d303fc9831b49693d4b\"},\"headline\":\"From Safety to Approval: RET Lung Cancer Clinical Trial Phases\",\"datePublished\":\"2024-09-16T08:00:44+00:00\",\"dateModified\":\"2026-03-02T15:53:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/happylungsproject.org\/from-safety-to-approval-ret-lung-cancer-clinical-trial-phases\/\"},\"wordCount\":2207,\"publisher\":{\"@id\":\"https:\/\/happylungsproject.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/happylungsproject.org\/from-safety-to-approval-ret-lung-cancer-clinical-trial-phases\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/happylungsproject.org\/wp-content\/uploads\/2024\/09\/phase-I-trial-phase-ii-trial-phase-iii-trial-for-cancer-patients.jpg\",\"articleSection\":[\"Clinical Trials\",\"Research\",\"Treatment\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/happylungsproject.org\/from-safety-to-approval-ret-lung-cancer-clinical-trial-phases\/\",\"url\":\"https:\/\/happylungsproject.org\/from-safety-to-approval-ret-lung-cancer-clinical-trial-phases\/\",\"name\":\"From Safety to Approval: RET Lung Cancer Clinical Trial Phases\",\"isPartOf\":{\"@id\":\"https:\/\/happylungsproject.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/happylungsproject.org\/from-safety-to-approval-ret-lung-cancer-clinical-trial-phases\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/happylungsproject.org\/from-safety-to-approval-ret-lung-cancer-clinical-trial-phases\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/happylungsproject.org\/wp-content\/uploads\/2024\/09\/phase-I-trial-phase-ii-trial-phase-iii-trial-for-cancer-patients.jpg\",\"datePublished\":\"2024-09-16T08:00:44+00:00\",\"dateModified\":\"2026-03-02T15:53:07+00:00\",\"description\":\"The lung cancer clinical trials phased approach ensures that new treatments are thoroughly evaluated before they are widely available.\",\"breadcrumb\":{\"@id\":\"https:\/\/happylungsproject.org\/from-safety-to-approval-ret-lung-cancer-clinical-trial-phases\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/happylungsproject.org\/from-safety-to-approval-ret-lung-cancer-clinical-trial-phases\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/happylungsproject.org\/from-safety-to-approval-ret-lung-cancer-clinical-trial-phases\/#primaryimage\",\"url\":\"https:\/\/happylungsproject.org\/wp-content\/uploads\/2024\/09\/phase-I-trial-phase-ii-trial-phase-iii-trial-for-cancer-patients.jpg\",\"contentUrl\":\"https:\/\/happylungsproject.org\/wp-content\/uploads\/2024\/09\/phase-I-trial-phase-ii-trial-phase-iii-trial-for-cancer-patients.jpg\",\"width\":813,\"height\":621,\"caption\":\"phase I trial, phase ii trial, phase iii trial for cancer patients\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/happylungsproject.org\/from-safety-to-approval-ret-lung-cancer-clinical-trial-phases\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/happylungsproject.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"From Safety to Approval: RET Lung Cancer Clinical Trial Phases\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/happylungsproject.org\/#website\",\"url\":\"https:\/\/happylungsproject.org\/\",\"name\":\"The Happy Lungs Project\",\"description\":\"Finding dependable treatments and ultimately a cure for RET Positive NSCLC.\",\"publisher\":{\"@id\":\"https:\/\/happylungsproject.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/happylungsproject.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/happylungsproject.org\/#organization\",\"name\":\"The Happy Lungs Project\",\"url\":\"https:\/\/happylungsproject.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/happylungsproject.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/happylungsproject.org\/wp-content\/uploads\/2021\/07\/HAPPY-LUNGS-LOGOS_stacked-full-color-e1632760868380.png\",\"contentUrl\":\"https:\/\/happylungsproject.org\/wp-content\/uploads\/2021\/07\/HAPPY-LUNGS-LOGOS_stacked-full-color-e1632760868380.png\",\"width\":1500,\"height\":1575,\"caption\":\"The Happy Lungs Project\"},\"image\":{\"@id\":\"https:\/\/happylungsproject.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/thehappylungsproject\",\"https:\/\/www.instagram.com\/thehappylungsproject\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/happylungsproject.org\/#\/schema\/person\/7f7dfd38ae877d303fc9831b49693d4b\",\"name\":\"Irene Guijarro Munoz\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/happylungsproject.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/b203420602dc287c938d2e2de2a2da59b7a2f94264288a3f345af4be6737c07a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/b203420602dc287c938d2e2de2a2da59b7a2f94264288a3f345af4be6737c07a?s=96&d=mm&r=g\",\"caption\":\"Irene Guijarro Munoz\"},\"description\":\"Irene Guijarro Munoz, Director of Research Irene Guijarro Munoz joined the Happy Lungs Project (HLP) as Director of Research in 2022. She oversees and coordinates the RET research program at HLP, including the studies that are currently being funded by HLP and conducted at four major US cancer centers. She assists with the development of RET research funding proposals and coordinates collaborations between the academic investigators and commercial contractors. In addition, she helps lung cancer patients and their families in the understanding of the RET positive lung cancer biology and the potential treatment options available. She has a scientific background and she completed a PhD in Biochemistry, Molecular Biology and Biomedicine, a Master of Biotechnology, and a Bachelor\u2019s Degree in Biochemistry at Universidad Aut\u00f3noma de Madrid, Spain, where she is originally from.\",\"sameAs\":[\"https:\/\/happylungsproject.org\/irene-our-director-of-ret-lung-cancer-research\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"From Safety to Approval: RET Lung Cancer Clinical Trial Phases","description":"The lung cancer clinical trials phased approach ensures that new treatments are thoroughly evaluated before they are widely available.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/happylungsproject.org\/from-safety-to-approval-ret-lung-cancer-clinical-trial-phases\/","og_locale":"en_US","og_type":"article","og_title":"From Safety to Approval: RET Lung Cancer Clinical Trial Phases","og_description":"The lung cancer clinical trials phased approach ensures that new treatments are thoroughly evaluated before they are widely available.","og_url":"https:\/\/happylungsproject.org\/from-safety-to-approval-ret-lung-cancer-clinical-trial-phases\/","og_site_name":"The Happy Lungs Project","article_publisher":"https:\/\/www.facebook.com\/thehappylungsproject","article_published_time":"2024-09-16T08:00:44+00:00","article_modified_time":"2026-03-02T15:53:07+00:00","og_image":[{"width":813,"height":621,"url":"https:\/\/happylungsproject.org\/wp-content\/uploads\/2024\/09\/phase-I-trial-phase-ii-trial-phase-iii-trial-for-cancer-patients.jpg","type":"image\/jpeg"}],"author":"Irene Guijarro Munoz","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Irene Guijarro Munoz","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/happylungsproject.org\/from-safety-to-approval-ret-lung-cancer-clinical-trial-phases\/#article","isPartOf":{"@id":"https:\/\/happylungsproject.org\/from-safety-to-approval-ret-lung-cancer-clinical-trial-phases\/"},"author":{"name":"Irene Guijarro Munoz","@id":"https:\/\/happylungsproject.org\/#\/schema\/person\/7f7dfd38ae877d303fc9831b49693d4b"},"headline":"From Safety to Approval: RET Lung Cancer Clinical Trial Phases","datePublished":"2024-09-16T08:00:44+00:00","dateModified":"2026-03-02T15:53:07+00:00","mainEntityOfPage":{"@id":"https:\/\/happylungsproject.org\/from-safety-to-approval-ret-lung-cancer-clinical-trial-phases\/"},"wordCount":2207,"publisher":{"@id":"https:\/\/happylungsproject.org\/#organization"},"image":{"@id":"https:\/\/happylungsproject.org\/from-safety-to-approval-ret-lung-cancer-clinical-trial-phases\/#primaryimage"},"thumbnailUrl":"https:\/\/happylungsproject.org\/wp-content\/uploads\/2024\/09\/phase-I-trial-phase-ii-trial-phase-iii-trial-for-cancer-patients.jpg","articleSection":["Clinical Trials","Research","Treatment"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/happylungsproject.org\/from-safety-to-approval-ret-lung-cancer-clinical-trial-phases\/","url":"https:\/\/happylungsproject.org\/from-safety-to-approval-ret-lung-cancer-clinical-trial-phases\/","name":"From Safety to Approval: RET Lung Cancer Clinical Trial Phases","isPartOf":{"@id":"https:\/\/happylungsproject.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/happylungsproject.org\/from-safety-to-approval-ret-lung-cancer-clinical-trial-phases\/#primaryimage"},"image":{"@id":"https:\/\/happylungsproject.org\/from-safety-to-approval-ret-lung-cancer-clinical-trial-phases\/#primaryimage"},"thumbnailUrl":"https:\/\/happylungsproject.org\/wp-content\/uploads\/2024\/09\/phase-I-trial-phase-ii-trial-phase-iii-trial-for-cancer-patients.jpg","datePublished":"2024-09-16T08:00:44+00:00","dateModified":"2026-03-02T15:53:07+00:00","description":"The lung cancer clinical trials phased approach ensures that new treatments are thoroughly evaluated before they are widely available.","breadcrumb":{"@id":"https:\/\/happylungsproject.org\/from-safety-to-approval-ret-lung-cancer-clinical-trial-phases\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/happylungsproject.org\/from-safety-to-approval-ret-lung-cancer-clinical-trial-phases\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/happylungsproject.org\/from-safety-to-approval-ret-lung-cancer-clinical-trial-phases\/#primaryimage","url":"https:\/\/happylungsproject.org\/wp-content\/uploads\/2024\/09\/phase-I-trial-phase-ii-trial-phase-iii-trial-for-cancer-patients.jpg","contentUrl":"https:\/\/happylungsproject.org\/wp-content\/uploads\/2024\/09\/phase-I-trial-phase-ii-trial-phase-iii-trial-for-cancer-patients.jpg","width":813,"height":621,"caption":"phase I trial, phase ii trial, phase iii trial for cancer patients"},{"@type":"BreadcrumbList","@id":"https:\/\/happylungsproject.org\/from-safety-to-approval-ret-lung-cancer-clinical-trial-phases\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/happylungsproject.org\/"},{"@type":"ListItem","position":2,"name":"From Safety to Approval: RET Lung Cancer Clinical Trial Phases"}]},{"@type":"WebSite","@id":"https:\/\/happylungsproject.org\/#website","url":"https:\/\/happylungsproject.org\/","name":"The Happy Lungs Project","description":"Finding dependable treatments and ultimately a cure for RET Positive NSCLC.","publisher":{"@id":"https:\/\/happylungsproject.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/happylungsproject.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/happylungsproject.org\/#organization","name":"The Happy Lungs Project","url":"https:\/\/happylungsproject.org\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/happylungsproject.org\/#\/schema\/logo\/image\/","url":"https:\/\/happylungsproject.org\/wp-content\/uploads\/2021\/07\/HAPPY-LUNGS-LOGOS_stacked-full-color-e1632760868380.png","contentUrl":"https:\/\/happylungsproject.org\/wp-content\/uploads\/2021\/07\/HAPPY-LUNGS-LOGOS_stacked-full-color-e1632760868380.png","width":1500,"height":1575,"caption":"The Happy Lungs Project"},"image":{"@id":"https:\/\/happylungsproject.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/thehappylungsproject","https:\/\/www.instagram.com\/thehappylungsproject\/"]},{"@type":"Person","@id":"https:\/\/happylungsproject.org\/#\/schema\/person\/7f7dfd38ae877d303fc9831b49693d4b","name":"Irene Guijarro Munoz","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/happylungsproject.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/b203420602dc287c938d2e2de2a2da59b7a2f94264288a3f345af4be6737c07a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b203420602dc287c938d2e2de2a2da59b7a2f94264288a3f345af4be6737c07a?s=96&d=mm&r=g","caption":"Irene Guijarro Munoz"},"description":"Irene Guijarro Munoz, Director of Research Irene Guijarro Munoz joined the Happy Lungs Project (HLP) as Director of Research in 2022. She oversees and coordinates the RET research program at HLP, including the studies that are currently being funded by HLP and conducted at four major US cancer centers. She assists with the development of RET research funding proposals and coordinates collaborations between the academic investigators and commercial contractors. In addition, she helps lung cancer patients and their families in the understanding of the RET positive lung cancer biology and the potential treatment options available. She has a scientific background and she completed a PhD in Biochemistry, Molecular Biology and Biomedicine, a Master of Biotechnology, and a Bachelor\u2019s Degree in Biochemistry at Universidad Aut\u00f3noma de Madrid, Spain, where she is originally from.","sameAs":["https:\/\/happylungsproject.org\/irene-our-director-of-ret-lung-cancer-research\/"]}]}},"_links":{"self":[{"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/posts\/3652","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/comments?post=3652"}],"version-history":[{"count":4,"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/posts\/3652\/revisions"}],"predecessor-version":[{"id":3657,"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/posts\/3652\/revisions\/3657"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/media\/3654"}],"wp:attachment":[{"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/media?parent=3652"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/categories?post=3652"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/tags?post=3652"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}